| Literature DB >> 36249971 |
Samaneh Madani1, Afsane Ahmadi1, Firoozeh Shoaei-Jouneghani1, Mahsa Moazen1, Najmeh Sasani1.
Abstract
Axis I disorders are one of the major health burdens worldwide. Evidence suggests that Mediterranean diet has key biological factors associated with reducing the progression of these disorders. This systematic review aimed to clarify the relationship between Mediterranean diet and Axis I disorders. PubMed and Scopus databases were searched from January 2016 up to June 2021. Those observational studies in English language that assessed the relationship between Mediterranean diet and Axis I disorders (such as depression, anxiety, eating disorders, schizophrenia, etc.) were included in this review. The Newcastle-Ottawa Scale was used to evaluate the quality of studies. Thirty-six studies (15 cohorts, 19 cross-sectional, and 2 case-control) met the inclusion criteria. The results revealed that more than two-thirds of the studies (25 studies, 69.44%) had significant protective relationship between receiving Mediterranean diet and reducing the symptoms or incidence of Axis I disorders. Most studies were performed on depression (29 studies measured depression at least as one of the Axis I disorders), of which 72.41% reported an inverse relationship. There were also 9 studies on anxiety (studies that measured anxiety at least as one of the Axis I disorders), that 77.77% of them observed protective association. Moreover, majority of the studies (25 studies, 69.44%) had high quality, of which 76% found an inverse relationship. In conclusion, it seems that the Mediterranean diet can reduce the symptoms or the occurrence of Axis I disorders (especially depression and anxiety). However, more extensive review studies, particularly with interventional designs, are necessary to prove the result.Entities:
Keywords: Mediterranean diet; anxiety; axis I disorders; depression; eating disorders; systematic review
Year: 2022 PMID: 36249971 PMCID: PMC9548357 DOI: 10.1002/fsn3.2950
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 3.553
FIGURE 1Flow diagram of the literature search process and selection of articles
Summary of cohort studies exploring the association between the Mediterranean diet and Axis I disorders
| Study | Country | Subject characteristics/gender/age (baseline)/sample size | Method of exposure measurement | Outcome(s)/method of outcome(s) measurement | Follow‐ up duration | Results | Quality | |
|---|---|---|---|---|---|---|---|---|
| 1 | Cherian et al. ( | USA | Participants living in retirement communities and senior public housing units/Both sexes/80.4/ | FFQ/MDS/11 items/range 0–55 | Depression/CES‐D/10‐item | 6.53 years | No significant differences were observed between tertiles of MDS and incidence of depressive symptoms. | Good |
| 2 | Gianfredi et al. ( | Netherlands | A population enriched with T2DM/Female/59.9/ | FFQ/MDS/9 items/range 0–9 | Depression/PHQ‐9/9 items | 6.1 years | MD was not significantly associated with incident depressive symptoms. | Fair |
| 3 | Das et al. ( | Australia | Participants aged ≥70 years/Male/81.1/ | Standardized diet history questionnaire/MDS/used as a continuous variable | Depression/GDS/15 items | 3 years | There was no significant association between MD and incident GDS≥5 | Poor |
| 4 | Vall Castelló and Tubianosa ( | 27 European countries | Elderly individuals/female/64.99/ | Survey questions/Mediterranean diet/4 items | Depression/EURO‐D scale included in the SHARE questionnaire/12 items/range 0–12 | 6 years | A significant relationship was found between receiving MD and reducing depressive symptoms | Good |
| 5 | Recchia et al. ( | London | Adult participants from the Whitehall II study/both sexes/35–55/ | FFQ/tMDS/9 items/range 0–9 | Depression/CES‐D/20 items | 13 years | Higher tMDS score was associated with lower risk of recurrent depressive symptoms | Good |
| 6 | Winkens et al. ( | Netherlands | Dutch older adults/both sexes/66.7/ | FFQ/MDS/11 items/range 0–55 | Depression/CES‐D/20 items | 3 years | Significant negative correlation was found between MDS and depressive symptoms. | Poor |
| 7 | Fresán et al. ( | Spain | University graduates/both sexes/34/ | FFQ/MDS/9 items/range 0–9 | Depression/Being diagnosed with depression by a medical doctor or report of regular use of antidepressant medication | 10.4 years | Increased adherence to the Mediterranean diet was inversely associated with depression risk | Good |
| 8 | Ruiz‐Estigarribia et al. ( | Spain | Spanish university graduates without depression or chronic prevalent diseases/Both sexes/36.7/ | FFQ/MDS/8 items/range 0–8 | Depression/Having been diagnosed by a medical doctor or habitual new use of antidepressant treatments. | 10.4 years | A significant inverse association was observed for medium‐to‐high MDS adherence and risk of depression | Good |
| 9 | Elstgeest et al. ) | Netherlands | Participants in the LASA Nutrition and Food‐related Behaviour study (middle‐aged and older individuals)/both sexes/71.2/ | FFQ/MDS | Depression/CES‐D/20 items/range 0–60 | 14 years | Men with a long‐term depressive symptoms' history had lower MDS. (In cross‐sectional analyses, depressive symptoms were associated with lower MDS scores in men after adjustment for confounders.) | Good |
| 10 | Leone et al. ( | Spain | Previous students of the University of Navarra, Spanish registered professionals, and other university graduates/female/34.33/ | FFQ/MDS/9 items/range 0–9 | Anorexia or bulimia nervosa/Positively responding to the question of having been diagnosed with anorexia or bulimia nervosa by a physician | 9.4 years | A lower anorexia or bulimia nervosa risk was observed for upper categories of adherence to MD. | Good |
| 11 | Adjibade et al. ( | France | Participants of the SU.VI.MAX study without depression at baseline/both sexes/49.5/ | 24‐h dietary records/rMED/9 components/range 0–18 | Depression/CES‐D/20 descriptive statements/range 0–60 | 12.6 years | Higher rMED score was significantly associated with lower incident depressive symptoms in men, but not in women | Good |
| 12 | García‐Toro et al. ( | Spain | Patients with major depressive disorder, with mild to moderate depressive symptoms for at least 2 months/Both sexes/51/ | MEDAS/14‐item |
Depression/Major depression: MINI Depression severity: BDI‐II | 12 months | MEDAS was inversely associated with basal BDI. However, the longitudinal association was not significant. | Poor |
| 13 | Notara et al. ( | Greece | Acute coronary syndrome patients/both sexes/63.5/ | FFQ/MDS/11 items/range 0–55 | Depression/CES‐D/range 0–60 | 10 years | Patients with the highest MDS were less likely to suffer from high depressive symptoms | Good |
| 14 | Sánchez‐Villegas et al. ( | Spain | Spanish university graduates who did not have depression and did not take antidepressants at baseline/both sexes/37.8/ | FFQ/MDS/10 items/Participant obtained 0 to 100% adherence | Depression/Depression was defined as the habitual use of antidepressant drugs or self‐reported diagnosis of depression performed by a physician. | 8.5 years | MD was inversely associated with depression risk. | Good |
| 15 |
Lai et al. ( | Australia | Middle‐aged women/female/45–50/ | DQES v2/MDS/9 items (range 0–9) | Depression/CES‐D scale/10‐item | 12 years | A significant inverse association was found between MD and depressive symptoms. | Good |
Note: Ages are presented as mean or ranges, except for the studies of Kaufman‐Shriqui et al., 2021, Elstgeest et al., 2019, and Fresán et al., 2019 which were reported as median.
Abbreviations: BAI: Beck Anxiety Inventory, BDI‐II: Beck Depression Inventory, CES‐D: Center for Epidemiologic Studies Depression Scale, CIDI:Composite International Diagnostic Interview, CIDI‐SR: Inventory of Depressive Symptomatology‐Self Report, DQES v2: Dietary Questionnaire for Epidemiological Studies version 2, EURO‐D: European Union initiative to compare symptoms of Depression, FFQ: Food Frequency Questionnaire, GDS:Geriatric Depression Scale, MD: Mediterranean Diet, MDS: Mediterranean Diet Score, MEDAS: Mediterranean Diet Adherence Score, MINI: Mini International Neuropsychiatric Interview, NESDA: Netherlands Study of Depression and Anxiety, PHQ‐9: 9‐Item Patient Health Questionnaire, rMED: relative Mediterranean diet score, SHARE: Survey of Health, Ageing and Retirement in Europe, SU.VI.MAX: The Antioxidant Vitamins and Minerals Supplementation, tMDS: transformed Mediterranean Diet Score, T2DM: Type 2 Diabetes Mellitus.
Summary of cross‐sectional and case–control studies exploring the association between the Mediterranean diet and Axis I disorders
| Study | Country | Subject characteristics/gender/age/sample size | Method of exposure measurement | Outcome(s)/method of outcome(s) measurement | Results | Quality | |
|---|---|---|---|---|---|---|---|
| 1 | Mantzorou et al. ( | Greece | Elderly participants who were free of diseases/both sexes/74.97/ | MDS/Based on the median values, those with scores ≤25, 26–28, 29–31, and ≥32 were classified as very low, low, moderate, and high adherence, respectively | Depression/GDS | Higher MD adherence was strongly associated with less depressive symptoms. | Good |
| 2 | Vassou et al. ( | Greece | Participants with no clinical evidence of cardiovascular diseases, other atherosclerotic diseases, or chronic viral infections/both sexes/42.75/ | FFQ/MDS/11 items/range 0–55 |
Anxiety/STAI/20 items Depression/ZDRS/range 20–80 | MDS was inversely correlated with anxiety, but was positively correlated with depression. | Good |
| 3 | Riera‐Sampol et al. ( | Spain | Patients with cardiovascular risk factors from primary care centers/both sexes/62.2/ | MDS/14‐item/range 0–14 | Depression/PHQ‐9/range 0–20 | Higher MDS was associated with lower depression levels | Good |
| 4 | Sadeghi et al. ( | Iran | General adults from the project of “Studying the Epidemiology of Psycho‐Alimentary Health and Nutrition”/both sexes/36.54/ | FFQ/MDS/9 items/range 0–9 | Depression and anxiety/HADS/14 items/range 0–21 | Inverse associations were found between adherence to MD and depression or anxiety. | Good |
| 5 | Kaufman‐Shriqui et al. ( | This was an international study | Adult individuals/both sexes/33/ | I‐MEDAS/14‐item/range 0–17 | Anxiety/GAD‐7/7 items/range 0–21 | Higher anxiety score was associated with lower Mediterranean diet score | Poor |
| 6 | Trigueros et al. ( | Spain | Students of the University of Almeria/both sexes/23.58/ | KIDMED/16 items/ranges 0–12 | Anxiety/For exam anxiety, the Test Anxiety Inventory was applied. | Test anxiety was reversely related to MD. | Poor |
| 7 | Carlos et al. ( | Spain | University students without psychological diagnosis or drugs consumption/both sexes/21.42/ | KIDMED/16 items | Anxiety/STAI/40 items | Only trait‐anxiety was a predictive variable for adherence to MD and a direct relationship was found. | Good |
| 8 | Açik et al. ( | Turkey |
Participants who referred to the social facility of the Ankara Metropolitan Municipality./female/42.15/ | 24‐h dietary recall/PREDIMED/14 items/range 0–14 | Depression and anxiety/DASS/42 items/score range of 0–42 on each subscale | Higher PREDIMED score was associated with lower odds of depression or anxiety. | Good |
| 9 | Gibson‐Smith et al. ( | Netherlands | Participants were selected in different regions from the general population, in general practice and in mental health organizations (78% of baseline sample had a lifetime depressive or anxiety disorder)/both sexes/52/ | FFQ/MDS/11 items/range 0–55 |
Depression/IDS‐SR/30‐item/range 0–84 Anxiety/BAI/21 items/range 0–63 | The MDS had inverse significant relationships with depression and anxiety | Good |
| 10 | Vicinanza et al. ( | Italy | Geriatric medical outpatients/both sexes/73.11/ | MDQ/14‐item/range 0–14 | Depression/GDS/15‐item | Significant inverse association was found between the MDQ score and GDS. | Poor |
| 11 | Paans et al. ( | Netherlands | Healthy, remitted, and current patients from the Netherlands Study of Depression and Anxiety/both sexes/51.7/ | FFQ/MDS/11 items/range 0–55 | Depression/CIDI and IDS‐SR (30‐item, range 0–84) | Depression and severity of it were associated with lower MDS. | Good |
| 12 | Mahdavi‐Roshan et al. ( | Iran | Adults with cardiovascular disease risk factors/both sexes/58.33/ | MEDAS/14‐point | Depression/BDI/range 0–63 | No relationship was discovered between depression and dietary adherence after controlling for confounders. | Good |
| 13 | Costa et al. ( | Portugal | Inpatients and outpatients with schizophrenia/both sexes/44.57/ | FFQ/MDS/9 items/range 0–9 | Schizophrenia/Diagnosis of schizophrenia was based on the DSM‐5 criteria. | No significant difference was observed in MDS between inpatients and outpatients. | Poor |
| 14 | Masana et al. ( | Greece | Older adults without preexisting cardiovascular disease or other chronic diseases/both sexes/59.67/ | FFQ/MDS/range 0–55 | Anxiety/STAI/20‐item/range 20–80 | No significant relationship was observed between MD and anxiety. | Good |
| 15 | Masana et al. ( | Mediterranean islands | Older people living in the Mediterranean basin./Both sexes/74.2/ | MDS/11 items/range 0–55 | Depression/GDS/range 0–15 | Participants with mild or severe depression had lower adherence to MD. | Good |
| 16 | Gibson‐Smith et al. ( | Netherlands | Participants were recruited from the general population, general practice, and mental health organizations (78% of baseline sample had a lifetime depressive or anxiety disorder)/both sexes/52/ | FFQ/MDS/11 items/range 0–55 | Depression and anxiety/Presence of disorders by CIDI; Severity of depression by IDS‐SR/Severity of anxiety by BAI | Severity of depression or anxiety, or having both disorders currently was significantly associated with lower MDS. | Good |
| 17 | Pagliai et al. ( | Italy | Nonagenarians enrolled in the Mugello Study/both sexes/92.7/ | MDS/11 items/range 0–55 | Depression/GDS/15‐item | No significant differences were found for MDS between depressed and non‐depressed subjects. | Good |
| 18 | Hernández‐Galiot and Goñi ( | Spain | An elderly non‐institutionalized population/both sexes/81/ | 24‐h diet recall/MEDAS/14‐item/range 0–14 | Depression/GDS/range 0–15 | No relationship was found between the MEDAS and GDS. | Poor |
| 19 | Veronese et al. ( | North America | Patients with a high risk of knee osteoarthritis/both sexes/61.3/ | FFQ/MDS/11 items/range 0–55 | Depression/CES‐D/20‐item/range 0–60 | Higher MDS was associated with reduced depressive symptoms. | Good |
| 20 | Łojko et al. ( | Poland | Cases were patients treated for bipolar disorder for more than 5 years in the outpatient clinic. The control group was selected from local primary health services' users/both sexes/58.7/ | FFQ/MDS/11 items/range 0–55 | Bipolar patients had lower MDS compared to controls. | Poor | |
| 21 | Della Camera et al. ( | Italy | Patients with erection disorder or without erection disorder referred to an andrology department/male/64.3/ | MDQ/14 items | Depression/the Hamilton scale/21 items/range 0–23 | Strong adherence to MD showed protective effect against depression. | Poor |
Note: Ages are presented as mean.
Abbreviations: BAI: Beck Anxiety Inventory, BDI: Beck Depression Inventory, CES‐D: Center for Epidemiologic Studies Depression Scale, CIDI: Composite International Diagnostic Interview, DASS: Depression Anxiety Stress Scales, DSM‐5: Diagnostic and Statistical Manual of Mental Disorders, FFQ: Food Frequency Questionnaire, GDS: Geriatric Depression Scale, GAD‐7: 7‐item Generalized Anxiety Disorder Scale, HADS: Hospital Anxiety and Depression Scale, I‐MEDAS: Israeli Mediterranean diet screener, IDS‐SR: Inventory of Depressive Symptomatology‐Self Report, KIDMED: Mediterranean Diet Quality Index, LASA: Longitudinal Aging Study Amsterdam, MDS: Mediterranean Diet Score, MDQ: Med‐Diet Questionnaire, MEDAS: Mediterranean Diet Adherence Screener, MD: Mediterranean Diet, PHQ‐9: 9‐item Patient Health Questionnaire, PREDIMED: Prevention with Mediterranean Diet, STAI: State–Trait Anxiety Inventory, ZDRS: Zung Self‐Rating Depression Scale.
All the studies are cross‐sectional, except for the last two studies that had adopted case–control design.
| First author | year | Selection | Comparability | Outcome | Total quality | |
|---|---|---|---|---|---|---|
| 1 | Cherian, L | 2021 | *** | ٭ | ٭٭ | Good |
| 2 | Gianfredi, V | 2021 | ** | ٭٭ | ٭٭ | Fair |
| 3 | Das, A | 2021 | *** | ٭٭ | ٭ | Poor |
| 4 | Vall Castelló, J | 2020 | *** | ٭٭ | ٭٭ | Good |
| 5 | Recchia, D | 2020 | *** | ٭٭ | ٭٭ | Good |
| 6 | Winkens, L | 2020 | **** | ٭ | ٭ | Poor |
| 7 | Fresán, U | 2019 | ٭٭٭٭ | ٭٭ | ٭٭٭ | Good |
| 8 | Ruiz‐Estigarribia, L | 2019 | ٭٭٭٭ | ٭٭ | ٭٭ | Good |
| 9 | Elstgeest, LEM | 2019 | *** | ٭٭ | ٭٭ | Good |
| 10 | Leone, A | 2018 | ٭٭٭ | ٭٭ | ٭٭ | Good |
| 11 | Adjibade, M | 2018 | ٭٭٭٭ | ٭٭ | ٭٭ | Good |
| 12 | García‐Toro, M | 2016 | **** | * | – | Poor |
| 13 | Notara, V | 2016 | *** | * | ** | Good |
| 14 | Sánchez‐Villegas, A | 2016 | **** | ٭٭ | ٭٭ | Good |
| 15 | Lai, JS | 2016 | *** | ** | ** | Good |
Each star is equal to one score in each category of quality assessment.
| First author | Year | Selection | Comparability | Outcome | Total quality | |
|---|---|---|---|---|---|---|
| 1 | Mantzorou, M | 2021 | ٭٭٭٭* | ٭٭ | ٭٭ | Good |
| 2 | Vassou, C | 2021 | ٭٭٭٭٭ | ٭٭ | ٭٭٭ | Good |
| 3 | Riera‐Sampol, A | 2021 | ٭٭٭ | ٭٭ | ٭٭ | Good |
| 4 | Sadeghi, O | 2021 | ٭٭٭٭ | ٭٭ | ٭٭ | Good |
| 5 | Kaufman‐Shriqui, V | 2021 | ٭٭٭٭٭ | – | ٭٭ | Poor |
| 6 | Trigueros, R | 2020 | ٭٭٭٭ | – | ٭ | Poor |
| 7 | Carlos, M | 2020 | ٭٭٭ | * | ٭٭ | Good |
| 8 | Açik, M | 2020 | ٭*٭٭ | ٭٭ | ٭٭ | Good |
| 9 | Gibson‐Smith, D | 2020 | ٭٭٭٭٭ | ٭٭ | ٭٭٭ | Good |
| 10 | Vicinanza, R | 2020 | ٭٭ | ٭٭ | ٭ | Poor |
| 11 | Paans, NPG | 2019 | **٭٭٭ | ٭٭ | ٭٭ | Good |
| 12 | Mahdavi‐Roshan, M | 2019 | ٭٭٭ | ٭* | ٭٭ | Good |
| 13 | Costa, R | 2019 | ٭٭٭ | – | ** | Poor |
| 14 | Masana, MF | 2019 | ٭٭٭ | ٭٭ | ٭٭ | Good |
| 15 | Masana, MF | 2018 | ٭٭٭ | ٭ | ٭٭ | Good |
| 16 | Gibson‐Smith, D | 2018 | ٭٭٭٭٭ | ٭٭ | ٭٭٭ | Good |
| 17 | Pagliai, G | 2018 | ٭٭٭ | ٭٭ | ٭٭ | Good |
| 18 | Hernández‐Galiot, A | 2017 | ٭٭٭ | – | ٭ | Poor |
| 19 | Veronese, N | 2016 | *٭٭٭٭ | ٭٭ | ٭٭ | Good |
Each star is equal to one score in each category of quality assessment.
| First author | Year | Selection | Comparability | Exposure | Total quality | |
|---|---|---|---|---|---|---|
| 1 | Łojko, D | 2019 | ٭٭٭ | – | ٭ | Poor |
| 2 | Della Camera, PA | 2017 | ٭ | – | ٭٭٭ | Poor |
Each star is equal to one score in each category of quality assessment.